Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAR100842 in diffuse cutaneous systemic sclerosis
2012-001369-34Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in systemic sclerosis (SSc) comparing SAR100842 with Placebo (2 arms). Started Jun 2012; status: completed.
02
Drugs
fipaxalparant
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on 2012-001369-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001369-34.